Pascale Boël

Title: Pascale Boël: Innovator in Cellular Abnormality Research

Introduction

Pascale Boël is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of cellular abnormalities, particularly in identifying individuals suffering from such conditions. Her innovative work has led to advancements in treatment methodologies.

Latest Patents

Pascale Boël holds a patent titled "METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HLA-CW 1601/MAGE-1 DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS." This patent focuses on peptides that bind to HLA-Cw*1601 molecules and stimulate the proliferation of cytolytic T cells. The patent includes specific peptides outlined in SEQ ID NOS: 4 and 5, which are crucial for the treatment of affected individuals. She has 1 patent to her name.

Career Highlights

Pascale Boël is associated with the Ludwig Institute for Cancer Research Limited, where she continues her research and development efforts. Her work is instrumental in advancing our understanding of cellular abnormalities and their treatment.

Collaborations

Pascale has collaborated with notable colleagues in her field, including Pierre Van Der Bruggen and Jean-Pierre Szikora. These collaborations have further enriched her research and contributed to the scientific community.

Conclusion

Pascale Boël is a dedicated inventor whose work in cellular abnormalities has the potential to impact many lives. Her innovative approaches and collaborations highlight her commitment to advancing medical research and treatment options.